Developmental outcome of 9-year-old children born after PGS: follow-up of a randomized trial

AbstractSTUDY QUESTIONDoes Day-3 cleavage-stage PGS affect neurodevelopment of 9-year-old IVF offspring?SUMMARY ANSWERWe did not find evidence of adverse consequences of Day-3 cleavage-stage PGS on neurodevelopment of 9-year-old IVF offspring, although children born after IVF with or without PGS often had a non-optimal neurological condition.WHAT IS KNOWN ALREADYKnowledge on long-term sequelae for development and health of children born following PGS is lacking. This is striking as evidence accumulates that IVF itself is associated with increased risk for impaired health and development in the offspring.STUDY DESIGN SIZE, DURATIONThis prospective, assessor-blinded, multicentre, follow-up study evaluated development and health of 9-year-old IVF children born to women who were randomly assigned to IVF with PGS (PGS group) or without PGS (control group). The follow-up examination at 9 years took place between March 2014 and May 2016.PARTICIPANTS/MATERIALS, SETTING, METHODSIn total, 408 women were included and randomly assigned to IVF with or without Day-3 cleavage-stage PGS. This resulted in 52 ongoing pregnancies in the PGS group and 74 in the control group. In the PGS group, 59 children were born alive; in the control group, 85 children were born alive. At the age of 9 years, 43 children born after PGS and 56 control children participated in the study. Our primary outcome was the neurological optimality score, a sensitive measure of neurological condition assessed with a stand...
Source: Human Reproduction - Category: Reproduction Medicine Source Type: research